Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

We report the fourth described case of severe toxic rhabdomyolysis occurring in an 81-year-old woman caused by the concomitant administration of palbociclib taken at the usual dosage (125 mg per day) and simvastatin. To the best of our knowledge, this is the first reported case successfully treated...

Full description

Bibliographic Details
Main Authors: François Poumeaud, Anna Fontanier, Jérémie Dion, Quentin Mathevet, Olivier Cointault, Emmanuelle Uro-Coste, Céline Marty, Florence Dalenc, Pierre Girardie, Anaïs Rataboul
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
rhabdomyolysis
palbociclib
simvastatin
interaction
myositis
plasmatic exchange
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1026434/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1026434/full

Similar Items